<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The American National Cancer Institute (NCI) guidelines set the limit of activity for crude plants extracts at 50% inhibition (IC
 <sub class="sub">50</sub>) of proliferation to be &lt; 30 
 <italic class="italic">μ</italic>g/mL after the exposure time of 72 hours [
 <xref rid="B19" ref-type="bibr" class="xref">19</xref>]. Accordingly, it appears that
 <italic class="italic"> T. aphylla</italic> AE and EE are potentially potent cytotoxic extracts against MCF-7 cell line, with IC
 <sub class="sub">50</sub> values (
 <italic class="italic">μ</italic>g/mL) of 2.17 ± 0.10 and 26.65 ± 3.09, respectively. Doxorubicin and cisplatin's respective IC
 <sub class="sub">50</sub> values against MCF-7 cells are 0.01 ± 0.001 and 1.17 ± 0.13. Both extracts unfortunately lacked cytotoxic potential against Panc-1 or Caco-2 cell lines in the tested concentration range. Regarding the safety profile on normal fibroblasts, both extracts of
 <italic class="italic"> T. aphylla</italic> demonstrated higher safety compared with doxorubicin and cisplatin. Figures 
 <xref ref-type="fig" rid="fig2" class="xref">2</xref>
 <xref ref-type="fig" rid="fig3" class="xref"/>
 <xref ref-type="fig" rid="fig4" class="xref"/>–
 <xref ref-type="fig" rid="fig5" class="xref">5</xref> illustrate the different effects of the tested extracts and control drugs.
</p>
